The Clorox Company (NYSE:CLX) Given Consensus Rating of “Reduce” by Brokerages

The Clorox Company (NYSE:CLX) has received a consensus rating of “Reduce” from the sixteen research firms that are currently covering the stock, Marketbeat.com reports. Five research analysts have rated the stock with a sell recommendation, ten have assigned a hold recommendation and one has assigned a buy recommendation to the company. The average 12 month price objective among brokers that have covered the stock in the last year is $117.9333.

A number of research firms recently commented on CLX. Wells Fargo & Company lifted their price target on Clorox from $108.00 to $115.00 and gave the stock an “equal weight” rating in a research note on Friday, January 23rd. TD Cowen lifted their target price on Clorox from $108.00 to $111.00 and gave the stock a “hold” rating in a research report on Wednesday. Barclays reiterated an “underweight” rating and issued a $109.00 price target on shares of Clorox in a report on Friday, January 16th. UBS Group raised their price objective on Clorox from $115.00 to $121.00 and gave the stock a “neutral” rating in a research note on Wednesday. Finally, Royal Bank Of Canada set a $132.00 price objective on shares of Clorox in a report on Wednesday.

Insider Buying and Selling at Clorox

In related news, Director Pierre R. Breber acquired 4,000 shares of Clorox stock in a transaction that occurred on Friday, November 21st. The stock was acquired at an average price of $104.13 per share, for a total transaction of $416,520.00. Following the transaction, the director directly owned 13,000 shares of the company’s stock, valued at $1,353,690. This trade represents a 44.44% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 0.63% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Clorox

A number of hedge funds have recently added to or reduced their stakes in the stock. Nomura Asset Management Co. Ltd. lifted its stake in shares of Clorox by 9.0% in the 2nd quarter. Nomura Asset Management Co. Ltd. now owns 335,514 shares of the company’s stock valued at $40,285,000 after purchasing an additional 27,639 shares during the last quarter. Hudson Bay Capital Management LP bought a new position in Clorox during the second quarter valued at about $8,568,000. Vanguard Personalized Indexing Management LLC lifted its position in shares of Clorox by 64.2% in the third quarter. Vanguard Personalized Indexing Management LLC now owns 25,732 shares of the company’s stock worth $3,173,000 after buying an additional 10,065 shares during the last quarter. Vise Technologies Inc. bought a new stake in shares of Clorox during the 2nd quarter worth about $328,000. Finally, Brookstone Capital Management increased its holdings in shares of Clorox by 1,395.4% during the 3rd quarter. Brookstone Capital Management now owns 94,332 shares of the company’s stock valued at $11,631,000 after acquiring an additional 88,024 shares during the last quarter. 78.53% of the stock is currently owned by institutional investors.

More Clorox News

Here are the key news stories impacting Clorox this week:

• Positive Sentiment: Morgan Stanley raised its price target to $136 (equal-weight), signaling meaningful upside versus the current level and providing buy-side support. Article Title
• Positive Sentiment: Jefferies kept a Buy rating and a high target (~$151), reinforcing a bullish view on longer-term recovery and giving investors a favorable risk/reward case. Article Title
• Neutral Sentiment: Clorox reiterated its 2026 outlook despite mixed Q2 results, which limits downside if management delivers on guidance and execution. Article Title
• Neutral Sentiment: Clorox will present at the CAGNY conference (Feb. 19), offering investors a near-term opportunity for management to outline strategy and provide more color on ERP integration and potential M&A (GOJO). Article Title
• Negative Sentiment: Q2 results were mixed: adjusted EPS missed estimates ($1.39 vs. $1.43), organic sales fell year-over-year, and margin pressure from higher costs and ERP-related expenses was highlighted — primary near-term negative catalyst. Article Title
• Negative Sentiment: Evercore cut its target sharply to $115 and kept an Underperform rating, increasing sell-side pressure and signalling concerns about near-term profitability. Article Title
• Negative Sentiment: Deutsche Bank trimmed its target to $112 (hold), and TD Cowen’s $111 target (hold) also implies downside — several shops are skeptical on margins and the ERP/integration timeline. Article Title Article Title
• Negative Sentiment: BofA flagged margin uncertainty after the Q2 miss even while nudging its target to $112 — a reminder margins and execution (inventory reset, ERP) are the biggest risks near term. Article Title

Clorox Stock Down 0.1%

Shares of NYSE:CLX opened at $117.59 on Friday. The firm has a market cap of $14.22 billion, a PE ratio of 19.21, a price-to-earnings-growth ratio of 0.57 and a beta of 0.59. The company has a fifty day simple moving average of $105.58 and a 200 day simple moving average of $114.01. The company has a current ratio of 0.74, a quick ratio of 0.50 and a debt-to-equity ratio of 71.03. Clorox has a 12-month low of $96.66 and a 12-month high of $159.04.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Tuesday, February 3rd. The company reported $1.39 EPS for the quarter, missing analysts’ consensus estimates of $1.43 by ($0.04). The company had revenue of $1.67 billion for the quarter, compared to the consensus estimate of $1.64 billion. Clorox had a net margin of 11.17% and a return on equity of 383.01%. The company’s revenue was down .8% compared to the same quarter last year. During the same quarter last year, the company earned $1.55 earnings per share. On average, equities research analysts anticipate that Clorox will post 7.15 EPS for the current fiscal year.

Clorox Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 13th. Stockholders of record on Wednesday, January 28th will be issued a $1.24 dividend. The ex-dividend date of this dividend is Wednesday, January 28th. This represents a $4.96 annualized dividend and a dividend yield of 4.2%. Clorox’s payout ratio is 81.05%.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.